FIELD: medicine.
SUBSTANCE: for the purpose of individual prediction of developing acute post-infarction cardiac aneurysm in the patients suffering large-focal myocardial infarction associated with type 2 diabetes mellitus, clinical and laboratory parameters are evaluated on the first day after admission to hospital. A probability is calculated by formula: the probability of developing aneurism = -5.97561 + 2.29343× interventricular septum thickness + 0.115033× triglycerides -0.110837× total cholesterol -0.0143738× heart rate per minute + 0.676339× end-diastolic dimension + 0.598774× Killip class of acute heart failure - 0.00988886× length of arterial hypertension + 0.0951111× blood glucose + 0.0165178× glycohemoglobin - 0.274047× remodelling type + 0.18664× sex - 0.0175495× age + 0.114326× length of diabetes mellitus. Interventricular septum thickness, left ventricular end-diastolic dimension are expressed in cm; triglycerides, total cholesterol, blood glucose and glycohemoglobin are expressed in mole/l; length of diabetes mellitus and age are expressed in years. Myocardial remodelling type is assessed by a score scale - the absence of hypertrophy means 0 points; the concentric hypertrophy means 1 point; the concentric remodelling 2 points; the eccentric hypertrophy means 3 points. 0 Points are assigned to females, and 1 point is assigned to males. The systolic and diastolic pressure levels are expressed in mm Hg. If the derived coefficient makes 0.8 and more, a high probability of developing acute post-infarction cardiac aneurysm is stated. If the coefficient is less than 0.8, a probability of developing acute post-infarction cardiac aneurysm is considered to be minimal.
EFFECT: method enables maximally accurate prediction of developing acute post-infarction cardiac aneurysm on the first day of myocardial infarction.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREDICTING OUTCOME OF MYOCARDIUM INFARCTION IN PATIENTS WITH DIABETES MELLITUS | 2009 |
|
RU2420228C2 |
METHOD OF PREDICTING THE DEVELOPMENT OF LEFT VENTRICULAR ANEURYSM IN PATIENTS AFTER MYOCARDIAL INFARCTION, TAKING INTO ACCOUNT GENETIC FACTORS | 2022 |
|
RU2801684C1 |
METHOD FOR TREATING VENTRICULAR EXTRASYSTOLE THE CASES OF MYOCARDIAL INFARCTION | 2000 |
|
RU2197241C2 |
METHOD FOR PREDICTION OF DEVELOPMENT OF MYOCARDIAL INFARCTION COMPLICATION | 2008 |
|
RU2373542C1 |
METHOD FOR EVALUATING RISK OF REMOTE DEATH AND NONFATAL CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE | 2014 |
|
RU2570089C1 |
METHOD FOR IDENTIFICATION LONG-TERM MORTALITY RISK AND NEFTAL CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE | 2017 |
|
RU2649964C1 |
METHOD OF PREDICTING OUTCOME OF CARDIOCEREBRAL PATHOLOGY IN PATIENTS WITH DIABETES MELLITUS | 2009 |
|
RU2420227C2 |
METHOD FOR PREDICTING THE RISK OF DEVELOPING LIFE-THREATENING VENTRICULAR ARRHYTHMIAS IN WOMEN WITH CORONARY HEART DISEASE IN COMBINATION WITH TYPE 2 DIABETES MELLITUS AND HYPOTHYROIDISM | 2017 |
|
RU2663630C1 |
METHOD FOR PREDICTING LEFT ATRIAL APPENDAGE THROMBOSIS IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION | 2021 |
|
RU2781152C1 |
METHOD FOR PREDICTING ADVERSE OUTCOMES UP TO 12 MONTHS IN PATIENTS WITH ACUTE CORONARY SYNDROME | 2020 |
|
RU2747693C1 |
Authors
Dates
2012-12-20—Published
2011-04-05—Filed